401564-36-1
Product Name:
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
Formula:
C13H20N2O4S
Inquiry
SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
| Molecular Weight | 300.38 g/mol |
|---|---|
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 300.11437830 g/mol |
| Monoisotopic Mass | 300.11437830 g/mol |
| Topological Polar Surface Area | 92.2 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 433 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
RELATED SUPPLIERS
Aalidhra Pharmachem Pvt Ltd
1Y
product:401564-36-1 3-((S)-1-tert-Butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine 98%
Vercali Pharma
1Y
product:(2beta,3alpha,5alpha,16beta,17beta)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane 401564-36-1 98%
Soujanya Life Sciences
1Y
product:3-((S)-1-tert-Butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine 98%
Ralington Pharma
1Y
product:401564-36-1 3-((S)-1-tert-Butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine 98%
Actis Generics Pvt Ltd
1Y
product:3-((S)-1-tert-Butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine 401564-36-1 98%